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Objectives: To determine if a sensitive D-dimer assay can exclude progression to organ dysfunction, 
death, and intensive care unit (ICU) admission in patients presenting to the emergency department 
(ED) with suspected infection, and if increasing levels of D-dimer are predictive of those end points. 
Methods: The study took place at two academic EDs, both located in tertiary care hospitals. This was 
a prospective convenience sample of adult patients presenting with an infective process and at least 
two of four criteria for the Systemic Inflammatory Response Syndrome. We measured D-dimer levels 
in the participants and abstracted their records for the end points. Sensitivity and specificity were 
calculated and receiver operating characteristic analysis was performed to determine if a higher cutoff 
would have a greater specificity for our end points. 
Results: We enrolled 134 patients. Twelve were excluded from analysis (10 for lack of a D-dimer, 
one for recent surgery, and one for complete loss to follow up). Using the cutoff of 0.4 established by 
our laboratories as positive, the D-dimer had a sensitivity of 94% (CI95; 76-99) for organ dysfunction 
in the ED, 93% (72-99) for organ dysfunction at 48 hours, 93% (81-98) for ICU admission, and 100% 
(63-100) for 30-day mortality. However, at this cutoff, specificity was not statistically significant. 
Significantly raising the cutoff for a positive resulted in a decrease in sensitivity but improved 
specificity. 
Conclusion: This study was limited by its nonconsecutive patient recruitment and sample size. A 
normal D-dimer may exclude progression to organ dysfunction, ICU admission, and death and, at 
higher cutoff levels, could help risk stratify patients presenting to the ED with signs of sepsis. 
[West J Emerg Med. 2010;11(2):173-179.]
INTRODUCTION
Background
Patients presenting to the emergency department (ED) 
in septic shock have been shown to benefit from early 
goal-directed therapy aimed at improving perfusion1 and 
early antibiotic therapy.2 Our tools are currently limited in 
predicting which ED patients with an infection, but without 
overt sepsis or organ dysfunction, will progress to severe 
sepsis, shock, or death. The Systemic Inflammatory Response 
Syndrome (SIRS) criteria, while part of the definition of 
sepsis, are not adequately sensitive or specific to be used 
alone to predict the clinical course of a patient.3 A predictive 
biomarker could be helpful to clinicians to risk-stratify 
infected patients to an appropriate level of care. 
Importance
As a candidate biomarker of sepsis, fibrin D-dimer 
stands apart in its availability in the ED. It has demonstrated 
sensitivity for sepsis in ICU patients.4,5 Additionally, it has 
been correlated with other potential markers of sepsis and is 
a potential predictor of mortality and organ system failure.6-9 
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of D-dimer and severity of disease in hospitalized patients 
with community-acquired pneumonia. These studies have 
focused primarily on patients requiring ICU-level care and 
have not examined a broader patient population, therefore 
limiting application of the data to ED patients. However, not 
all studies have shown the D-dimer to be useful early in the 
course of sepsis. Iba et al.11 in 2007 failed to show a difference 
in D-dimer levels on Day 0, but a difference appeared on Day 
2. In an ED pilot study, D-dimer had a sensitivity of only ~61-
67% for patients who ultimately were found to have positive 
blood cultures.12 This study used a semi-quantitative D-dimer 
assay and only looked at blood culture results without looking 
at clinical outcomes. If the early correlation of D-dimer 
levels with illness severity described in ICU patients could be 
reproduced in the ED population, the D-dimer could be used 
to better risk stratify patients with infections into appropriate 
levels of care.
Goals of This Investigation
We sought to determine if the D-dimer is an appropriate 
test in the initial evaluation for sepsis. Our primary hypotheses 
are that the D-dimer is adequately sensitive to exclude organ 
dysfunction, ICU requirement, and mortality in patients 
presenting with clinical presentations consistent with sepsis, 
and that higher levels of D-dimer are predictive of organ 
dysfunction, ICU requirement, and death. We considered 
a sensitivity ≥ 90% clinically important and desired to 
demonstrate 95% confidence intervals of 10% or less. A test 
with these characteristics would potentially help determine 
which patients (who typically would be admitted to a ward 
level of care) would benefit from more intensive monitoring or 
aggressive therapy.
METHODS
Study Design 
We performed a prospective, observational study using 
a combination of prospective laboratory analysis and chart 
auditing to investigate the correlation between a positive 
D-dimer and the end points of hospital admission, initial 
ICU admission, organ dysfunction, and 30-day mortality. 
Our sample size was calculated to be 116 patients, based on 
the estimate of a relative risk of 5.5 for mortality in patients 
with an elevated D-dimer compared to those with normal 
D-dimers,7 and 50% of the patients having positive D-dimers. 
Setting
All patients in the study visited the EDs at two tertiary-
care military medical centers from August 2007 through 
March 2008. The institutional review board approved and 
monitored the study at both institutions. 
Selection of Participants
All adult patients presenting to the ED regardless of mode 
of arrival with a suspected infection (radiographic, laboratory, 
or clinical findings indicating a need for antibiotics), as 
determined by the treating team’s attending physician and/or 
third year resident and at least two out of four SIRS criteria 
(Table 1), were eligible for enrollment. The presence of two or 
more of the four SIRS criteria was established as a criterion to 
focus the study on a higher acuity level of infection consistent 
with the diagnostic criteria for sepsis (Table 2). Patients 
with a history of thromboembolic disease, recent surgery, 
or those in basic military training (due to issues with follow 
up and ethical issues centered on ability to consent) were 
excluded. Pregnant women and patients with cancer were not 
excluded from the study. Patients were identified, consented, 
and enrolled as a convenience sample by senior resident and 
attending physicians in the ED at the time of presentation. 
Next of kin or powers of attorney were allowed to provide 
consent in incapacitated patients.
Data Collection
Patients who agreed to participate in the study had blood 
samples sent separately from their clinical lab work for 
measurement of their D-dimer levels. All laboratory work 
including the D-dimer assay was performed by the institutions’ 
regular lab facilities. The treating teams did not have access 
to the D-dimer results unless they had ordered a separate 
D-dimer study as part of their clinical evaluation. To evaluate 
end organ dysfunction we ordered a complete metabolic panel, 
complete blood count, PTT, PT, and serum lactate as part of 
the study. The results from these studies were available to 
the ED and admitting teams. Data from the ED encounter 
(SIRS criteria, suspected infection, and disposition) were 
entered on a standard data sheet by the enrolling physician. 
ICU admission was determined by the admitting service 
in conjunction with the emergency physicians. Generally, 
patients requiring vasopressor support, ventilator support, or 
close monitoring as determined by the admitting service were 
Table 1. Systemic Inflammatory Response Syndrome Criteria
Temperature <36 degrees C or >38 degrees C
Heart Rate >90 beats per minute
Respiratory Rate >20 breaths/min or PaCO2 <32 mm Hg
White Blood
Cell Count
>12,000 cells/mm3, <4,000 cells/mm3, or 
>10% bands
Table 2. Sepsis Definitions
Sepsis 2 or more symptoms of inflammation and 
presumed/confirmed infection
Severe Sepsis Sepsis + Organ Dysfunction
Septic Shock Sepsis + hypotension not reversed by fluid 
resuscitation.
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admitted to the ICU teams. The primary investigator then 
used the same sheet to abstract the patients’ ED and inpatient 
charts through the next 30 days for evidence of the primary 
end points. Laboratory results, including lactate, coagulation 
panels, chemistry panels, and blood counts, were abstracted 
as well. Patients were called at the end of the 30-day follow-
up period to confirm that no other hospitalizations occurred 
outside the primary medical system. After all other variables 
were abstracted the D-dimer result was added to the datasheet. 
The primary investigator was not blinded to the study 
objectives during the abstraction phase. 
Methods of Measurements
We used the Liatest D-dimer assay (Diagnostica 
Stago, Parsippany, New Jersey), a quantitative, microlatex 
agglutination test with a reference cut-off of 0.4 mg/dL 
as positive. The assay is run on venous blood collected 
in calcium citrate tubes. This assay is the same assay 
used in the evaluation of thromboembolic disease at both 
of our institutions. We utilized the Sepsis-related Organ 
Failure Assessment (SOFA) to determine the presence of 
organ dysfunction. The SOFA score uses measurements 
of cardiovascular, neurologic, coagulation, hepatic, renal, 
and respiratory function to create a composite score. We 
maintained the convention of a SOFA score of three or 
greater as positive for significant organ dysfunction.13 When 
explicit data needed to calculate a complete SOFA score were 
missing from the record the patient was assigned the least 
dysfunctional value for that system and were included in the 
data analysis. Mortality was determined using a combination 
of the inpatient and ED records and telephone follow up. After 
the 30-day follow up was completed, the primary investigator 
transferred the de-identified data into a password protected 
Microsoft Access (Microsoft, 2007) database. 
Primary Data Analysis
We used SPSS 16.0 (SPSS, 2007) to compute descriptive 
statistics of the participants and to determine the sensitivity, 
specificity, odds ratio, positive likelihood ratio and negative 
likelihoods associated with a cut point of 0.4 mg/dL. We then 
constructed receiver operating characteristic (ROC) curves 
for each of the study end points, and a D-dimer cut point at 
~95% specificity was evaluated for its sensitivity, odds ratio, 
and positive and negative likelihood ratios. Selected randomly, 
10% of the records (14) were abstracted by a second reviewer 
blinded to D-dimer results, and inter-rater variability was 
evaluated using the kappa statistic. 
In a 1996 article Gilbert and Lowenstein described 
Figure 1. Outcomes for all enrolled patients.
Table 3
Demographics
Average Age 59 Range (19-93) std dev= 21
Gender 45% Male 55% Female
Presenting Infection Number Percentage
Pulmonary 69 57%
Urinary 14 11%
Intra-abdominal 21 17%
Neurologic 3 2%
Oropharyngeal 5 4%
Skin/Soft tissue 10 8%
Severity of Illness
Mean # of SIRS 
Criteria
2.5 Range (2-4)
Mean lactate 1.7 Range (0.6-5.8) std dev= 1.0
MSOF in ED 16 13%
Admissions 99 81%
Average length of 
stay (days)
5.3 Range (1-30) std dev= 5.4
ICU admissions 29 24%
Average ICU stay 
(days)
4.7 Range (1-24) std dev= 5.5
MSOF at 48 hours 14 11%
MSOF within 30 Days 25 20%
In-hospital deaths 5 4%
30-days mortality 6 5%
SIRS, systemic inflammatory response syndrome; MOSF, 
multisystem organ failure; ICU, intensive care unit
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eight criteria of a quality retrospective review study. Those 
criteria are trained abstractors, explicit case-selection criteria, 
definition of variables, abstraction forms, meetings among 
abstractors and study coordinators, monitoring of abstractor 
performance, blinding of abstractors to study goals, and 
testing of interrater agreement.1,4 We used a single abstractor, 
who was not blinded to the study objectives, but remained 
blinded to D-dimer results until after the other data points 
were abstracted. Selection criteria and variable definition 
were explicitly defined a priori. Abstractor performance was 
monitored through the blinded re-abstraction of a random 
10% of the charts by a blinded second abstractor and then 
calculating interrater reliability with a kappa statistic. Other 
than the lack of complete blinding of the primary abstractor, 
Gilbert and Lowenstein’s criteria were met. 
RESULTS
We enrolled 134 patients in the study from August 2007 
to March 2008. Twelve patients were excluded from data 
analysis, 10 for lack of a D-dimer (due to hemolysis or loss 
of the sample), one for a recent surgery, and one for complete 
loss to follow up. Demographic data is presented in Table 3. 
There were no discrepancies between the abstractors in the 
recording of the primary variables of interest, (admission, ICU 
admission, organ dysfunction in the ED, organ dysfunction 
at 48 hours, organ dysfunction during the 30-day follow up, 
in-hospital death, and 30-day mortality), giving a kappa of 1.0 
(95% CI; 0.5-1.0). 
Figures 1 and 2 show the outcomes of patients entered in 
to the study. Thirty-day mortality was 5%, 24% were admitted 
to the ICU, and 20% had SOFA scores greater than three at 
any point in the 30-day follow-up period. 
Retrospectively using quality improvement data collected 
separately from our study, we estimate that 60 patients were 
admitted to the ICU with sepsis through both of our EDs 
during the study period and we were only able to enroll 29. 
If the same proportion of ambulatory and ward patients was 
missed, then we were only able to enroll an estimated 50% of 
the eligible patients.
Figure 2. Outcomes for all admitted patients.
 
Figure 3. Receiver operator characteristic curve for intensive care 
unit admission. D-dimer area under the curve 0.79 (95% CI 0.69-
0.89) Lactate area under the curve 0.65 (95% CI 0.52-0.78).
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The D-dimer was associated most closely with the need 
for ICU level care. At a level of 0.4 mg/dL the sensitivity 
was 93% (95% CI 81-98) and specificity was 16% (95% 
CI 12-18). However, other measures of association did not 
reach statistical significance. Odds ratio was 2.6 (95% CI 
0.62-11), positive likelihood ratio 1.1 (95% CI 0.93-1.2), and 
negative likelihood ratio was 0.43 (95% CI 0.11-1.5). After 
ROC analysis (Figure 3) we found that 95% specificity was 
achieved with a D-dimer level of 4.0 mg/dL. At this cut off 
sensitivity was 35% (95% CI 23-43), the odds ratio was 9.3 
(95% CI 2.9-29), the positive likelihood ratio was 6.4 (95% 
CI 2.5-17), and the negative likelihood ratio was 0.69 (95%CI 
0.58-0.85).
Using the D-dimer to evaluate which patients would have 
a SOFA score greater than three at 48 hours from admission 
gave a sensitivity of 93% (95% CI 72-99) and a specificity of 
15% (95% CI 12-16). Other measures of association did not 
reach statistical significance, with an odds ratio of 2.3 (95% 
CI 0.35-14), positive likelihood ratio of 1.1 (95% CI 0.82-1.2), 
and a negative likelihood ratio of 0.48 (95% CI 0.08-2.3) at 
D-dimer cut off of 0.4 mg/dL. ROC analysis (Figure 4) gave a 
D-dimer level of 7.0 mg/dL as 94% specific, with a sensitivity 
of 29% (95% CI 13-47), odds ratio 6.8 (95% CI 1.7-27), 
positive likelihood ratio of 5.1 (95% CI 1.7-15), and negative 
likelihood ratio of 0.76 (95% CI 0.55-0.95)
For 30-day mortality, a D-dimer level of 0.4 mg/dL or 
greater gave a sensitivity of 100% (95% CI 63-100), failing to 
achieve our desired degree of precision. The remaining tests 
were not significant with a specificity of 15% (95% CI 13-15), 
an odds ratio of ∞ (95% CI 0.25-∞), a negative likelihood 
ratio of 0 (95% CI 0-2.9), and a positive likelihood ratio of 1.2 
(CI 95% 0.73-1.2). Using the ROC curve (Figure 5), a 95% 
specificity for 30-day mortality occurred at a D-dimer level 
of 9.0 mg/dL, and had a sensitivity of 17% (CI 95% 3-52), an 
odds ratio of 3.1 (95% CI 0.44-24), a positive likelihood ratio 
of 2.8 (95% CI 0.46-12), and a negative likelihood ratio of 
0.89 (CI 95% 0.51-1).
Lactate levels were available in 102 of the 122 patients. 
We generated ROC curves using the data from these 
102 patients for the end points of ICU admission, organ 
dysfunction at 48 hours, and 30- day mortality. These curves 
are shown in Figures 3-5 for comparison with the curves for 
the D-dimer data. 
DISCUSSION
Our results suggest that the D-dimer could be used 
as a screening test in the ED to exclude significant organ 
dysfunction, intensive care requirement, and possibly 
mortality in patients with suspected infection and SIRS. 
While the values for the sensitivity of the test were above our 
90% threshold, the confidence intervals remained too wide 
to definitively state that the test is adequate to use by itself in 
determining the disposition of patients from the ED. At the 
typical cut off for normal (0.4 mg/dL) the odds ratio, positive 
likelihood ratio, negative likelihood ratio and specificity failed 
to reach significance. 
In this study the D-dimer performed better as a positive 
predictor at cut points 10-20 times greater than normally 
used for thromboembolic disease. Specifically in the setting 
of organ dysfunction, the test might provide useful clinical 
positive predictive power. These odds ratios at the higher 
cutoffs were in a range that could allow the test to be used 
   
Figure 4. Receiver operator characteristic curve for Organ Dys-
function at 48 hours. D-dimer area under the curve 0.74 (95% CI 
0.56-0.92). Lactate area under the curve 0.78 (95% CI 0.63-0.94). 
Figure 5. Receiver operator characteristic curve for 30-days 
mortality. D-dimer area under the curve 0.72 (95% CI 0.55-0.89). 
Lactate area under the curve 0.65 (95% CI 0.37-0.74).
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alone or in a panel of tests to increase or decrease the pretest 
probability. However, the value of the useful cut point was 
different for different end points, and requires prospective 
validation in a larger study to be of use clinically.
Notably, the D-dimer was elevated in the nine patients 
who had not yet developed organ dysfunction, but who went 
on to do so later in their hospital course (Figure 2). Patients 
who demonstrate severe sepsis or shock early in their hospital 
course generally have more severe organ dysfunction, but 
they may have a decreased mortality rate and decreased length 
of stay in the ICU when compared to patients who develop 
sepsis later in their hospital course.15 Utilizing the D-dimer in 
the early testing of patients with suspected sepsis may help to 
identify these patients earlier in their illness.
LIMITATIONS
The primary limitation of our study is its sample size and 
convenience patient sampling. We estimate that only 50% of 
patients eligible to be enrolled during the study period were 
enrolled, and this reflects in the wide confidence intervals 
for the test characteristics computed. Particularly, this lack 
of power limits our ability to comment on the ability of the 
D-dimer to exclude or predict mortality. 
Additionally, not all data points were available for all 
patients. This may have lead to an underestimation of the 
patients’ SOFA scores and a resulting underestimation of the 
number of patients suffering from organ dysfunction. This 
underestimation of the degree of organ dysfunction likely 
would skew our results away from confirming our hypotheses 
given the number of patients with elevated D-dimers. 
We kept our study population relatively broad with no 
exclusion criteria for patients with renal disease, cancer, 
pregnancy, or advanced age to better mirror an actual ED 
population. These populations can have higher D-dimer levels 
than a young healthy population and represent a possible 
confounding variable in our results.
Our lack of universal screening for thromboembolic 
disease creates a potential confounder. One patient in this 
study was found to have a pulmonary embolism during 
a subsequent hospitalization. She was diagnosed with 
pneumonia and sepsis syndrome during her initial evaluation 
and her blinded D-dimer was 1.85 at that time. One week 
later, she returned to the ED and was diagnosed with a 
pulmonary embolism by CT angiography. Given the large 
percentage of D-dimers in our study, positive D-dimers are 
not likely to be useful in distinguishing pneumonia from 
pulmonary embolism. Ordering angiograms solely on the basis 
of a D-dimer in our population would lead to overutilization 
of ionizing radiation.
CONCLUSION
Our preliminary study demonstrated that the fibrin D-dimer 
is a potentially sensitive diagnostic test for use in the exclusion 
of organ dysfunction, need for intensive care unit admission and 
30-day mortality with ROC curves similar to serum lactate, but 
has poor specificity at usual D-dimer thromboembolism cutoffs. 
As a confirmatory test for the presence of organ dysfunction the 
assay performed well enough at higher cut points (10-20 times 
normal) to potentially be used as a component of a model or 
scoring system, but not well enough to use as a stand-alone test. 
These higher cutoffs must be tested a priori in a larger patient 
sample to validate their potential use. 
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